PROBIOTIX HEALTH PLC (PBX) — Results for the year ended 31 December 2024

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the PROBIOTIX HEALTH PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time via the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. And I'd now like to hand you over to Steen Anderson, CEO. Good morning, sir. Good morning. Thank you, everyone, and thank you very much for joining this morning's presentation on the 2024 results and a little bit of an outlook into 2025 as well. Before we get started, let me introduce myself. My name is Steen Anderson. I'm CEO of PROBIOTIX HEALTH, and I've been working for the company since 2023. I'm a Danish national. I've been in the industry for thirty years, worked with several, large international ingredient nutraceutical companies and built, businesses from startup structures to maturation. Mark, if you would be kind enough to maybe put a few words on yourself. Certainly. Good morning. My name is Mark Kullingborn. I'm the CFO. I've been with PROBIOTIX since 2021, and I'm helped with the launch of PROBIOTIX as a stand alone company in March 2022. I've got twenty plus years experience in PLCs, life sciences, small companies of all shapes and sizes, and looking forward to going forward with it. Very good. Great. Thank you, Mark. So before we get started with the presentation, just have a brief look at our forward looking statement. So we have formalities in place. The, tod...